Literature DB >> 6485288

[Clinical manifestations of squamous cell carcinoma of the rectum].

R A Mel'nikov, L G Goshchitskiĭ, V K Kovalev.   

Abstract

The report deals with an evaluation of the data on 107 cases of squamous cell carcinoma of the rectum. 63 patients (58.8%) had proctological diseases in their case histories. Anal carcinoma is being misdiagnosed at out-patient hospitals as some other proctologic lesion in 34.9%. This fact points to the staff's lack of knowledge of the clinical picture of squamous cell carcinoma of the rectum. Abdominal-perineal extirpation of the rectum was the most frequent procedure used in the treatment of squamous cell carcinoma.

Entities:  

Mesh:

Year:  1984        PMID: 6485288

Source DB:  PubMed          Journal:  Vopr Onkol        ISSN: 0507-3758


  5 in total

1.  Aggressive treatment of metastatic squamous cell carcinoma of the rectum to the liver: a case report and a brief review of the literature.

Authors:  Theodosios K Theodosopoulos; Athanasios D Marinis; Nikolaos A Dafnios; John G Vassiliou; Lazaros D Samanides; Eleni E Carvounis; Vassilios E Smyrniotis
Journal:  World J Surg Oncol       Date:  2006-08-08       Impact factor: 2.754

Review 2.  Squamous cell cancer of the rectum.

Authors:  Tara Dyson; Peter V Draganov
Journal:  World J Gastroenterol       Date:  2009-09-21       Impact factor: 5.742

Review 3.  Synchronous Squamous Cell Carcinoma of the Anorectum and Proctosigmoid-a Case Report.

Authors:  Y C Madhu
Journal:  Indian J Surg       Date:  2017-12-23       Impact factor: 0.656

4.  Squamous cell carcinoma of rectum presenting in a man: a case report.

Authors:  A Syed Sameer; Nidda Syeed; Nissar A Chowdri; Fazl Q Parray; Mushtaq A Siddiqi
Journal:  J Med Case Rep       Date:  2010-11-30

5.  Comparison of outcomes between rectal squamous cell carcinoma and adenocarcinoma.

Authors:  Max S Chiu; Vivek Verma; Nathan R Bennion; Abhijeet R Bhirud; Jinluan Li; Mary E Charlton; Chandrakanth Are; Chi Lin
Journal:  Cancer Med       Date:  2016-10-26       Impact factor: 4.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.